BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nonaka M, Morimoto S. Experimental models of inherited cardiomyopathy and its therapeutics. World J Cardiol 2014; 6(12): 1245-1251 [PMID: 25548614 DOI: 10.4330/wjc.v6.i12.1245]
URL: https://www.wjgnet.com/1949-8462/full/v6/i12/1245.htm
Number Citing Articles
1
Sarah A. Dick, Slava Epelman. Chronic Heart Failure and InflammationCirculation Research 2016; 119(1): 159 doi: 10.1161/CIRCRESAHA.116.308030
2
Chen-Ching Yuan, Katarzyna Kazmierczak, Jingsheng Liang, Zhiqun Zhou, Sunil Yadav, Aldrin V. Gomes, Thomas C. Irving, Danuta Szczesna-Cordary. Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice Proceedings of the National Academy of Sciences 2018; 115(10) doi: 10.1073/pnas.1716925115
3
Fernando Pierin Peres-Filho, Suelen Umbelino da Silva, Fernando Pierin Peres, Leandra Ernst Kerche. Heart Failure Treatment with SGLT2 Inhibitors: A Systematic Review with Meta-AnalysisABC Heart Fail Cardiomyop 2024; 4(4) doi: 10.36660/abchf.20240060i
4
Fernando Pierin Peres-Filho, Suelen Umbelino da Silva, Fernando Pierin Peres, Leandra Ernst Kerche. Tratamento da Insuficiência Cardíaca com Inibidores de SGLT2: Uma Revisão Sistemática com MetanáliseABC Heart Failure & Cardiomyopathy 2024; 4(4) doi: 10.36660/abchf.20240060
5
J. H. Kirkels, N. de Jonge. Clinical Cardiogenetics2016; : 137 doi: 10.1007/978-3-319-44203-7_8
6
Brian R. Thompson, Michelle L. Asp, Joseph M. Metzger. Congestive Heart Failure and Cardiac Transplantation2017; : 151 doi: 10.1007/978-3-319-44577-9_10
7
Christopher T. Pappas, Rachel M. Mayfield, Christine Henderson, Nima Jamilpour, Cathleen Cover, Zachary Hernandez, Kirk R. Hutchinson, Miensheng Chu, Ki-Hwan Nam, Jose M. Valdez, Pak Kin Wong, Henk L. Granzier, Carol C. Gregorio. Knockout of Lmod2 results in shorter thin filaments followed by dilated cardiomyopathy and juvenile lethalityProceedings of the National Academy of Sciences 2015; 112(44): 13573 doi: 10.1073/pnas.1508273112
8
Timothy J. Cashman, Rebecca Josowitz, Bryce V. Johnson, Bruce D. Gelb, Kevin D. Costa, Vincenzo Lionetti. Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic CardiomyopathyPLOS ONE 2016; 11(1): e0146697 doi: 10.1371/journal.pone.0146697
9
Yuanyuan Dai, Nadezda Ignatyeva, Hang Xu, Ruheen Wali, Karl Toischer, Sören Brandenburg, Christof Lenz, Julius Pronto, Funsho E. Fakuade, Samuel Sossalla, Elisabeth M. Zeisberg, Andreas Janshoff, Ingo Kutschka, Niels Voigt, Henning Urlaub, Torsten Bloch Rasmussen, Jens Mogensen, Stephan E. Lehnart, Gerd Hasenfuss, Antje Ebert. An Alternative Mechanism of Subcellular Iron Uptake Deficiency in CardiomyocytesCirculation Research 2023; 133(2) doi: 10.1161/CIRCRESAHA.122.321157
10
Tarek Khedro, Jason M. Duran, Eric D. Adler. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem CellsCurrent Cardiology Reports 2022; 24(6): 631 doi: 10.1007/s11886-022-01683-8
11
Francesca Girolami, Giulia Frisso, Matteo Benelli, Lia Crotti, Maria Iascone, Ruggiero Mango, Cristina Mazzaccara, Kalliope Pilichou, Eloisa Arbustini, Benedetta Tomberli, Giuseppe Limongelli, Cristina Basso, Iacopo Olivotto. Contemporary genetic testing in inherited cardiac diseaseJournal of Cardiovascular Medicine 2018; 19(1): 1 doi: 10.2459/JCM.0000000000000589
12
Xin-Yi Wu, Yee-Ki Lee, Yee-Man Lau, Ka-Wing Au, Yiu-Lam Tse, Kwong-Man Ng, Chun-Ka Wong, Hung-Fat Tse. The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal ModelsPharmaceuticals 2024; 17(8): 1030 doi: 10.3390/ph17081030